Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats

Neuropharmacology

Volumn 39, Issue 5, 2000, Pages 873-880

  Wang, Y ^a   Chiang, Y H ^b   Su, T P ^a   Hayashi, T ^a   Morales, M ^a   Hoffer, B J ^a   Lin, S Z ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Glial cell line derived neurotrophic factor; Infarction; Ischemia; Neuroprotection; Vitamin D3

Indexed keywords

COLECALCIFEROL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM; CEREBRAL CORTEX; CHOLECALCIFEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HEMOGLOBINS; INFARCTION, MIDDLE CEREBRAL ARTERY; LIGATION; MALE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 0033972104     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00255-5     Document Type: Article

References (44)

1. Abe K., Hayashi T. Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Research. 776:1997;230-234.
2. Abe K., Hayashi T., Itoyama Y. Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain. Neuroscience Letters. 231:1997;37-40.
3. Barnett R.N., Skodon S.B., Goldberg M.H. Performance of "kits" used for clinical chemical analysis of calcium in serum. American Journal of Clinical Pathology. 59:1973;836-845.
4. Baudet C., Chevalier G., Naveilhan P., Binderup L., Brachet P., Wion D. Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line. Cancer Letters. 100:1996;3-10.
5. Brown R.D., Whisnant J.P., Sicks J.D., O'Fallon W.M., Wiebers D.O. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 27:1996;373-380.
6. Budd S.L. Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation. Pharmacological Therapeutics. 80:1998;203-229.
7. Chen S.T., Hsu C.Y., Hogan E.L., Maricq H., Balentine J.D. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 17:1986;738-743.
8. Chiang, Y.H., Lin, S.Z., Borlongan, C.V., Hoffer, B.J., Morales, M.F., Wang, Y., 1999. Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation. Journal of Cerebral Blood Flow and Metabolism, 19, 1329-1335.
9. Du C., Hu R., Csernansky C.A., Hsu C.Y., Choi D.W. Very delayed infarction after mild focal cerebral ischemia: a role for apotosis. Journal of Cerebral Blood Flow and Metabolism. 16:1996;195-201.
10. Garcion E., Nataf S., Berod A., Darcy F., Brachet P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Molecular Brain Research. 45:1997;255-267.
11. Hahn M., Lorez H., Fischer G. Effect of calcitriol in combination with corticosterone, interleukin-1beta, and transforming growth factor-beta1 on nerve growth factor secretion in an astroglial cell line. Journal of Neurochemistry. 69:1997;102-109.
12. Haussler M.R., Haussler C.A., Jurutka P.W., Thompson P.D., Hsieh J.C., Remus L.S., Selznick S.H., Whitfield G.K. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Journal of Endocrinology. 154(Suppl.):1997;57-73.
13. Humpel C., Hoffer B.J., Stromberg I., Bektesh S., Collins F., Olson L. Neurons of the hippocampal formation edxpress glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience. 59:1994;792-795.
14. Junger H., Varon S. Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro. Brain Research. 762:1997;56-60.
15. Kitagawa H., Hayashi T., Mitsumoto Y., Koga N., Itoyama Y., Abe K. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotropic factor after permanent middle cerebral artery occlusion in rats. Stroke. 29:1998;1417-1422.
16. Knuckey N.W., Finch P., Palm D.E., Primiano M.J., Johanson C.E., Flanders K.C., Thompson N.L. Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia. Molecular Brain Research. 40:1996;1-14.
17. Kokaia Z., Airaksinen M.S., Nanobashvili A., Larsson E., Kujamaki E., Lindvall O., Saarma M. GDNF family ligands and receptors are differentially regulated after brain insults in the rat. European Journal of Neuroscience. 11:1999;1202-1216.
18. Li X.Y., Xiao J.H., Feng X., Qin L., Voorhees J.J. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo. Journal of Investigative Dermatology. 108:1997;506-512.
19. Lin S.Z., Chiou A.L., Wang Y. Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke. 27:1996;747-752.
20. Magrassi L., Butti G., Pezzotta S., Infuso L., Milanesi G. Effects of vitamin D and retinoic acid on human glioblastoma cell lines. Acta Neurochir. (Wien). 133:1995;184-190.
21. Menotti A., Jacobs D.R., Blackburn H., Kromhout D., Nissinen A., Nedeljkovic S., Buzina R., Mohacek I., Seccareccia F., Giampaoli S., Dontas A., Aravanis C., Toshima H. Twenty-five-year prediction of stroke deaths in the seven countries study: the role of blood pressure and its changes. Stroke. 27:1996;381-387.
22. Naveilhan P., Berger F., Haddad K., Barbot N., Benabid A.L., Brachet P., Wion D. Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? Journal of Neuroscience Research. 37:1994;271-277.
23. Naveilhan P., ElShamy V.M., Emfors P. Differential regulation of mRNA for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. European Journal of Neuroscience. 9:1997;1450-1460.
24. Naveilhan P., Neveu I., Wion D., Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 7:1996;2171-2175.
25. Neveu I., Naveilhan P., Baudet C., Brachet P., Metsis M. 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. NeuroReport. 6:1994;124-126.
26. Okragly A.J., Haak-Frendscho M. An acid-treatment method for the enhanced detection of GDNF in biological samples. Experimental Neurology. 145:1997;592-596.
27. Perez-Pinzon M.A., Xu G.P., Dietrich W.D., Rosenthal M., Sick T.J. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism. 17:1997;175-182.
28. Przyklenk K., Hata K., Kloner R.A. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation. 96:1997;1305-1312.
29. Puchacz E., Stumpf W.E., Stachowiak E.K., Stachowiak M.K. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Molecular Brain Research. 36:1996;193-196.
30. Reeben M., Laurikainen A., Hiltunen J.O., Castren E., Saarma M. The messenger RNAs for both glial cell line-derived neurotrophic factor receptors, c-ret and GDNFR alpha, are induced in the rat brain in response to kainate-induced excitation. Neuroscience. 83:1998;151-159.
31. Robbins E.et al. Efficacy of orally administered CB 1093, an NGF-inducing vitamin D receptor ligand, in the fimbria fornix lesion model. Society of Neuroscience Abstracts. 23:1997;881-881.
32. Robertson W.G., Marshall R.W. Calcium measurements in serum and plasma - total and ionized. Critical Reviews in Clinical Laboratory Science. 11:1979;271-304.
33. Tuomilehto J., Rastenyte D., Sivenius J., Sarti C., ImmonenRaiha P., Kaarsalo E., Kuulasmaa K., Narva E.V., Salomaa V., Salmi K., Torppa J. Ten-year trends in stroke incidence and mortality in the FINMONICA stroke study. Stroke. 27:1996;825-832.
34. Veenstra T.D., Londowski J.M., Windebank A.J., Brimijoin S., Kumar R. Effects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells. Developmental Brain Research. 99:1997;53-60.
35. Veenstra T.D., Windebank A.J., Kumar R. 1,25-dihydroxyvitamin D3 regulates the expression of N-myc, c-myc, protein kinase C, and transforming growth factor-beta2 in neuroblastoma cells. Biochemistry and Biophysiology Research Communications. 235:1997;15-18.
36. Verity A.N., Wyatt T.L., Hajos B., Eglen R.M., Baecker P.A., Johnson R.M. Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. Journal of Neurochemistry. 70:1998;531-539.
37. Verity A.N., Wyatt T.L., Lee W., Hajos B., Baecker P.A., Eglen R.M., Johnson R.M. Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. Journal of Neuroscience Research. 55:1999;187-197.
38. Verlinden L., Verstuyf A., Mathieu C., Tan B.K., Bouillon R. Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-beta2 and their combinations. Journal of Steroid Biochemistry and Molecular Biology. 60:1997;87-97.
39. Virag L., Scott G.S., Antal-Szalmas P., O'Connor M., Ohshima H., Szabo C. Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Molecular Pharmacology. 56:1999;824-833.
40. Wang Y., Chiou A.L., Yang S.T., Lin J.C. Ketamine antagonizes hypoxia-induced dopamine release in rat striatum. Brain Research. 693:1995;233-245.
41. Wang Y., Lin S.Z., Chiou A.L., Williams L.R., Hoffer B.J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. Journal of Neuroscience. 17:1997;4341-4348.
42. Whitfield G.K., Hsieh J.C., Jurutka P.W., Selznick S.H., Haussler C.A., MacDonald P.N., Haussler M.R. Genomic actions of 1,25-dihydroxyvitamin D3. Journal of Nutrition. 125:1995;1690S-1694S.
43. Wu J., Garami M., Cheng T., Gardner D.G. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. Journal of Clinical Investigation. 97:1996;1577-1588.
44. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., Kato S. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 283:1999;1317-1321.